Development of porphyria cutanea tarda in a hemodialysis patient after reactivation of hepatitis C virus infection

Nephron. 2001 Jun;88(2):170-3. doi: 10.1159/000045980.

Abstract

Cases of porphyria cutanea tarda (PCT) are occasionally reported in hemodialysis patients. Recently, hepatitis C virus has been recognized as a precipitating factor of PCT. The activity of the liver disease may be critical for the appearance of PCT. In this regard, liver disease reactivation after treatment with interferon alpha (IFN-alpha) is a well-known phenomenon. We report the case of a hemodialysis patient who developed PCT coincidentally with reactivation of liver disease, immediately after treatment with IFN-alpha. Therefore, in the present case, reactivation of hepatitis after IFN-alpha withdrawal could be the triggering factor. The occurrence of a bout of PCT should be considered as a possible complication at the end of IFN-alpha therapy, if reactivation of the disease exists.

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / therapeutic use
  • Hepatitis C / complications*
  • Hepatitis C / metabolism
  • Humans
  • Hypertension, Malignant / complications
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Iron / therapeutic use
  • Kidney Failure, Chronic / complications
  • Liver Function Tests
  • Male
  • Middle Aged
  • Porphyria Cutanea Tarda / drug therapy
  • Porphyria Cutanea Tarda / etiology*
  • Recombinant Proteins
  • Renal Dialysis*

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Iron